Novel entities for cancer therapy

Novel entities for cancer therapy

  • CN 1,058,993 C
  • Filed: 08/29/1990
  • Issued: 11/29/2000
  • Est. Priority Date: 08/30/1989
  • Status: Active Grant
First Claim
Patent Images

1. a molecular chimera is used for the application of the medicine of cancer prodrug treatment in preparation, described mosaic comprises one can be by selectivity activated transcriptional control DNA sequence in mammalian cancer cells, and one effectively be connected with this transcriptional control DNA sequence and the DNA sequence of a kind of heterozyme of encoding, and described endonuclease capable catalysis prodrug is converted into the deleterious medicament of cancer cells.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×